Sobi to share new clinical data and research at EULAR 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 28 2025
0mins
Source: Yahoo Finance
Sobi's Presentation at EULAR 2025: Sobi will present new clinical data on Gamifant for macrophage activation syndrome, Vonjo for VEXAS treatment, and uncontrolled gout management at the European Congress of Rheumatology in Barcelona from June 11-14, 2025.
Symposium and Discussions: A symposium chaired by Dr. Sophie Georgin-Lavialle will focus on VEXAS syndrome, featuring presentations and a panel discussion to enhance understanding and treatment options for rheumatological conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
